Durvalumab
D9100C00001
Phase 3 mab completed
Quick answer
Durvalumab for Locally Advanced Cervical Cancer is a Phase 3 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Locally Advanced Cervical Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed